1、White PaperThe Landscape of NIPT in Abu DhabiUnderstanding the current use,challenges and potential of expanding use of Non-Invasive Prenatal Testing(NIPT)B|The Landscape of NIPT in Abu DhabiRestriction on disclosure statement 2025.All rights reserved.IQVIA is a registered trademark of IQVIA Inc.in

2、the United States,the European Union,and various other countries.All trademarks,trade names,product names,graphics,and logos of IQVIA,Quintiles,or IMS Health contained herein are trademarks or registered trademarks of IQVIA Holdings,Inc.,or its subsidiary,as applicable,in the United States and/or ot

3、her countries.All other trademarks,trade names,product names,graphics and logos contained herein are the property of their respective owners.The use or display of other parties trademarks,trade names,product names,graphics or logos is not intended to imply,and should not be construed to imply a rela

4、tionship with,or endorsement or sponsorship of IQVIA Holdings,Inc.,or its subsidiaries by such other party.Table of contentsExecutive summary 1Introduction 3Current prenatal testing landscape 4Non-Invasive Prenatal Testing(NIPT)5NIPT adoption across the globe 6The prenatal testing landscape and NIPT

5、 adoption in the Abu Dhabi 7Stakeholder perspectives on NIPT in Abu Dhabi 10Recommendations for expanding NIPT in Abu Dhabi 11Conclusion 14Appendix 15Glossary and abbreviations 15Acknowledgement 15References 16About the authors 19About IQVIA 20About Illumina 20Table of contents1|The Landscape of NIP

6、T in Abu DhabiExecutive summaryChromosomal abnormalities pose significant challenges for prenatal healthcare globally,leading to conditions such as Down syndrome(Trisomy 21),Edwards syndrome(Trisomy 18),and Pataus syndrome(Trisomy 13),which can result in severe cognitive and physical disabilities1.W